In fact,PPARα expression increases in the liver during fasting[35] and in several models of murine obesity [106].Chronic treatment of rodents with PPARα agonists such asfenofibrate or Wy 14643 increases hepatic UCP2 mRNAexpression [105–108]. The gene discussed is UCP2; the disease is obesity disorder.